BetterLife Pharma Inc. Files March 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Mar 5, 2024 · CIK: 1464165
| Field | Detail |
|---|---|
| Company | Betterlife Pharma INC. (BETRF) |
| Form Type | 6-K |
| Filed Date | Mar 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, disclosure
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its March 6-K, standard SEC disclosure.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on March 5, 2024, for the month of March 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in A1 and headquartered in Vancouver, BC. This filing is in accordance with Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates and disclosures required by the SEC for foreign private issuers, offering transparency to investors about the company's ongoing operations and compliance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure report (6-K) and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Registrant
- Pivot Pharmaceuticals Inc. (company) — Former Company Name
- Neurokine Pharmaceuticals Inc. (company) — Former Company Name
- Vancouver, BC (location) — Principal Executive Office Location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was BetterLife Pharma Inc. previously known by other names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change date: 20150417) and Neurokine Pharmaceuticals Inc. (name change date: 20090514).
Where is BetterLife Pharma Inc.'s principal executive office located?
The principal executive office of BetterLife Pharma Inc. is located at 1275 West 6th Avenue, #300, Vancouver, BC V6H 1A6.
Does BetterLife Pharma Inc. file annual reports under Form 20-F or Form 40-F?
BetterLife Pharma Inc. indicates it files annual reports under Form 20-F.
What is the SIC code for BetterLife Pharma Inc.?
The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 343 words · 1 min read · ~1 pages · Grade level 14.8 · Accepted 2024-03-05 15:41:39
Filing Documents
- betrf_6k.htm (6-K) — 10KB
- betrf_ex991.htm (EX-99.1) — 19KB
- betrf_ex991img3.jpg (GRAPHIC) — 4KB
- 0001477932-24-001031.txt ( ) — 36KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: March 5, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3